These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 18705308)

  • 1. Effect of chemoradiotherapy for neural invasion in an advanced esophageal cancer.
    Tanaka A; Ishikawa S; Okuno K; Shiozaki H
    Hepatogastroenterology; 2008; 55(84):963-6. PubMed ID: 18705308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New trends in neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer: esophagectomy--is it necessary?].
    Fujita H; Sueyoshi S; Tanaka T; Toh U; Mine T; Sasahara H; Shirouzu K; Yamana H; Toda Y; Hayabuchi N
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2016-22. PubMed ID: 11103231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome?
    Ruol A; Rizzetto C; Castoro C; Cagol M; Alfieri R; Zanchettin G; Cavallin F; Michieletto S; Da Dalt G; Sileni VC; Corti L; Mantoan S; Zaninotto G; Ancona E
    Ann Surg; 2010 Nov; 252(5):788-96. PubMed ID: 21037434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant therapy of esophageal cancer.
    Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
    Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of preoperative radio-chemotherapy in locally advanced squamous epithelial cancer of the esophagus].
    Nürnberger HR; Löffler T; Hausamen TU; Theophil B; Löhlein D
    Chirurg; 1993 Sep; 64(9):701-7; discussion 707-8. PubMed ID: 8222927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.
    Chao YK; Chan SC; Chang HK; Liu YH; Wu YC; Hsieh MJ; Tseng CK; Liu HP
    Eur J Surg Oncol; 2009 Mar; 35(3):289-94. PubMed ID: 18396384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
    Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
    J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of low-dose cisplatin and 5-fluorouracil as adjuvant chemoradiotherapy for advanced squamous cell carcinoma of the esophagus.
    Shimizu K; Hihara J; Yoshida K; Toge T
    Hiroshima J Med Sci; 2005 Sep; 54(3):67-71. PubMed ID: 16180698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
    Ishikawa H; Sakurai H; Tamaki Y; Nonaka T; Yamakawa M; Saito Y; Kitamoto Y; Higuchi K; Hasegawa M; Nakano T
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1290-6. PubMed ID: 16872312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between histological effects on the main tumors and nodal status after chemoradiotherapy for squamous cell carcinoma of the esophagus.
    Yano M; Yasuda T; Miyata H; Fujiwara Y; Takiguchi S; Monden M
    J Surg Oncol; 2005 Mar; 89(4):244-50; discussion 250. PubMed ID: 15726612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma.
    Gao XS; Qiao XY; Yang XR; Asaumi J; Zhou ZG; Wang YD; Zhou DA; Wan J; Kuroda M; Kishi K; Kawasaki S; Hiraki Y
    Oncol Rep; 2002; 9(4):767-72. PubMed ID: 12066206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent preoperative chemoradiotherapy for stage III or IV esophageal squamous carcinoma.
    Osaka Y; Takagi Y; Tsuchida A; Hoshino S; Tachibana S; Shinohara M; Aoki T
    Oncol Rep; 2004 Nov; 12(5):1121-6. PubMed ID: 15492803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus: impact of increased dosage on long-term results.
    de Manzoni G; Pedrazzani C; Laterza E; Pasini F; Grandinetti A; Bernini M; Ruzzenente A; Zerman G; Tomezzoli A; Cordiano C
    Ann Thorac Surg; 2005 Oct; 80(4):1176-83. PubMed ID: 16181836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perioperative chemotherapy of squamous cell cancer of the esophagus].
    Fink U; Pfeiffer G; Gossmann A; Preusser P; Wilke HJ; Siewert JR
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():107-10. PubMed ID: 1983489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001.
    Kenjo M; Uno T; Murakami Y; Nagata Y; Oguchi M; Saito S; Numasaki H; Teshima T; Mitsumori M
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):357-63. PubMed ID: 19735863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer].
    Zhang MY; Wang Z; Liu XY; Chen G; Liu FY
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.